These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36510693)

  • 1. The clinical relevance of quality of life in heart failure patients with preserved ejection fraction.
    Seo M; Watanabe T; Yamada T; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Tamaki S; Yasumura Y; Sotomi Y; Hikoso S; Nakatani D; Fukunami M; Sakata Y;
    ESC Heart Fail; 2023 Apr; 10(2):995-1002. PubMed ID: 36510693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
    Yang M; Kondo T; Talebi A; Jhund PS; Docherty KF; Claggett BL; Vaduganathan M; Bachus E; Hernandez AF; Lam CSP; Inzucchi SE; Martinez FA; de Boer RA; Kosiborod MN; Desai AS; Køber L; Ponikowski P; Sabatine MS; Solomon SD; McMurray JJV
    Eur J Heart Fail; 2024 Jul; 26(7):1524-1538. PubMed ID: 38700986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study.
    Kuan WC; Chee KH; Kasim S; Lim KK; Dujaili JA; Lee KK; Teoh SL
    J Med Econ; 2024; 27(1):607-617. PubMed ID: 38557412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining health-related quality of life in ambulatory adult patients with chronic heart failure: insights from Malaysia using EQ-5D-5L.
    Tan YJ; Ong SC; Yong VS; Khor WW; Pang LJ; Choong YY; Zameram AM; Tan LY; Voo JYH; Lam KK; Yen CH; Wahab MJA; Abdulla ZB
    Qual Life Res; 2024 Aug; 33(8):2181-2195. PubMed ID: 38839679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors associated with quality of life in heart failure patients considering the use of the generic EQ-5D-5L™ in primary care: new follow-up results of the observational RECODE-HF study.
    Boczor S; Eisele M; Rakebrandt A; Menzel A; Blozik E; Träder JM; Störk S; Herrmann-Lingen C; Scherer M;
    BMC Fam Pract; 2021 Oct; 22(1):202. PubMed ID: 34645408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient reported outcome in HFpEF: Sex-specific differences in quality of life and association with outcome.
    Faxén UL; Hage C; Donal E; Daubert JC; Linde C; Lund LH
    Int J Cardiol; 2018 Sep; 267():128-132. PubMed ID: 29957252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
    Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome.
    Sturkenboom R; Keszthelyi D; Brandts L; Weerts ZZRM; Snijkers JTW; Masclee AAM; Essers BAB
    Qual Life Res; 2022 Apr; 31(4):1209-1221. PubMed ID: 34546554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMT.
    Pleyer L; Heibl S; Tinchon C; Vallet S; Schreder M; Melchardt T; Stute N; Föhrenbach Quiroz KT; Leisch M; Egle A; Scagnetti L; Wolf D; Beswick R; Drost M; Larcher-Senn J; Grochtdreis T; Vaisband M; Hasenauer J; Zaborsky N; Greil R; Stauder R
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between locomotive syndrome and the Japanese version of the EQ-5D-5L in middle-aged and elderly people in Japan.
    Tanaka S; Ando K; Kobayashi K; Seki T; Hamada T; Machino M; Ota K; Morozumi M; Kanbara S; Ito S; Ishiguro N; Hasegawa Y; Imagama S
    Nagoya J Med Sci; 2020 Feb; 82(1):5-14. PubMed ID: 32273627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
    Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
    Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients.
    Mugii N; Someya F; Noto S; Hamaguchi Y; Matsushita T; Takehara K
    Mod Rheumatol; 2020 Jul; 30(4):681-686. PubMed ID: 31269847
    [No Abstract]   [Full Text] [Related]  

  • 16. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of EQ-5D-5L and SPVU-5D for measuring quality of life in patients with venous leg ulcers in an Australian setting.
    Cheng Q; Kularatna S; Lee XJ; Graves N; Pacella RE
    Qual Life Res; 2019 Jul; 28(7):1903-1911. PubMed ID: 30778889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the diversity and determinants of health-related quality of life measures in patients with acute heart failure.
    Patil D; Tang HJ; Kuo FH; Toh HS; Yang IN; Chang WT; Lee MC; Chung KN; Huang CY; Hsu WH; Chang TC; Shih JY; Liao CT
    ESC Heart Fail; 2024 Aug; 11(4):1963-1970. PubMed ID: 38509031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.
    Filippatos G; Maggioni AP; Lam CSP; Pieske-Kraigher E; Butler J; Spertus J; Ponikowski P; Shah SJ; Solomon SD; Scalise AV; Mueller K; Roessig L; Bamber L; Gheorghiade M; Pieske B
    Eur J Heart Fail; 2017 Jun; 19(6):782-791. PubMed ID: 28586537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.